Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARCTIC: Monitoring Adjusted Antiplatelet Treatment and DAPT Interruption
NCT00827411Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, prasugrel in coronary artery disease (CAD), acute coronary syndrome (ACS), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2009; status: completed.
02
Drugs
clopidogrelprasugrel
03
Conditions
coronary artery disease (CAD)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00827411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827411.